Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EXACTLY. Management made a very very positive statement which is good for the company and shareholders. No R/S in the future,reduced A/S from 14 Billion to 4Billion and game changing product launch.Whatelse we need?.
H*VE was 5 cents last year, its $1.32 today.SFOR will follow soon.
Cino Ltd are the Certified Global Distributors of SaveVchat
IS DEMO TODAY & TOMORROW?.
ANOTHER INSTITUTION BUY 21 MILLION SHARES AS YOU ARE SELLING LOL
Reported today 12/15
https://www.sec.gov/Archives/edgar/data/1285543/000110465920135558/tm2038349d1_sc13g.htm
This is nothing if the product is good.I assume it must be very good ,otherwise company would never announce about reducing A/S and no R/S.
Thanks for sharing.Great info and stars are aligning for this company and its shareholders.
BIOMETRIC AUTHENTICATION - NEVER HEARD OF IT ANYWHERE ELSE
https://drive.google.com/file/d/1DjhY2fEuEtPjzwSxjGnIrSGm29OB_F4_/view
Page 11/14
NO RS and AS reduction itself is a great indicator that SFOR will do very well IMO.
ZM is trading at $400/share with so many vulnerabilities. I do not worry about OS or AS for this company because of their product(s) SafeVchat.Its a better product in the market in video conferencing as per CEO.
CEO SAYS GREAT POINTS WHY THIS IS A GEM
Reducing A/S from 14 Billion to 4 Billion.
Very confident about SafeVChat and thats the reason for reducing A/S.
No R/S in the future.
SFO = Secured video conferencing + Securing computers.
Stars are aligning.
https://www.globenewswire.com/news-release/2020/12/15/2145388/0/en/StrikeForce-Intends-to-Reduce-its-Authorized-Shares-by-10Billion.html
SFOR = ZM + NORTON
https://twitter.com/SafeVchat_/status/1338564315826319362
HUMBL Announces Launch of Holiday Deal Days
https://www.globenewswire.com/news-release/2020/12/14/2144563/0/en/HUMBL-Announces-Launch-of-Holiday-Deal-Days.html
Things are getting started
Let us do the work for you this holiday season—Don’t miss out on great deals happening online today! #HUMBL #HUMBLpay $TSNP pic.twitter.com/RalsGMGiJM
— HUMBL (@HUMBLPay) December 14, 2020
My guess $1 by end of Monday.
Relief went up to 93 cents from 1 cents in 3 days with 2.2 Billion OS.
SFOR with 390 million could reach $5 in no time IMO.
It will trade into $1 - $5 in no time.JMO.
Penny.. where is ZM,Webex,Logmein..etc in your list?.
ZM is trading around $400 with so many security vulnarabilities.
SFOR should trade better than ZM soon after they golive.
Even at 1% of ZM, SFOR should be at $1.1 Billion ie almost $4/sh.But IMO, it should around $30 or $50 range even without a pandemic as the CEO says SafeVChat is the number one product and stars are aligning.
REDUCING A/S 14B to 4B - PROOF HERE
https://stocktwits.com/message/263795624
SafeV Chat better than Zoom Webex GoToMeeting Join.me MS Team BlueJeans Hangouts Facetime Skype Zoho
All these have the first 3 below features except SafeVChat which has all the features below.
Meeting Password
Passcode OTP
Encrypted Audio & Video
Meeting Authorization
Out-Of-Band Phone Authentication
Push & Biometric Authentication
Keyboard Encryption
Camera Protection
Microphone Protection
Audio Out Protection
Clipboard Protection
https://www.safevchat.com/
They need more shares to grow big like ZM.If the product is good,secure and better than any product in the market, why not it grow like ZM or better than ZM or any other competitor?.
They are actually releasing two products safeVchat and PrivacyLock.
Nice Q7.Good thing is SFOR is using its own security products for SafeVchat and SFOR is a cyber security company where as the competitors are not, that is the main advantage for SFOR and disadvantage for competitors.SFOR is positioned in a good spot and already lining up partners from different countries to sell the product.Even without any pandemic, this should be the Gold standard product as per CEO.
22 Million shares bought by Institution filed yesterday
https://www.sec.gov/Archives/edgar/data/1285543/000146970920000095/ccapsfor13g_120920apg.htm
HUMBL FORBES 2020 - UN2030 AGENDA
HUMBL
HUMBL founders Brian Foote and Michele Rivera noticed a major gap between the US and emerging markets regarding mobile payment. HUMBL uses a mobile wallet that connects debit, credit and digital dollars – with a point-of-sale (POS) system called HUMBL Hubs - to instantly connect the way money moves between consumers and merchants in markets such as LatAm, Africa, India and Oceania. HUMBL is working on Fortune 500 partnerships and was featured by the UN 2030 Agenda.
https://www.forbes.com/sites/marenbannon/2020/06/25/rising-startups-to-watch-with-diverse-founders/?sh=6198213c330d
HUMBL® Partners With Digital India Payments (DIPL) To Enter India Market
https://www.prnewswire.com/in/news-releases/humbl-r-partners-with-digital-india-payments-dipl-to-enter-india-market-879365178.html
FORBES 2020 COVERING HUMBL
https://www.forbes.com/sites/marenbannon/2020/06/25/rising-startups-to-watch-with-diverse-founders/?sh=554f96a9330dHUMBL
HUMBL founders Brian Foote and Michele Rivera noticed a major gap between the US and emerging markets regarding mobile payment. HUMBL uses a mobile wallet that connects debit, credit and digital dollars ? with a point-of-sale #$%$ system called HUMBL Hubs - to instantly connect the way money moves between consumers and merchants in markets such as LatAm, Africa, India and Oceania. HUMBL is working on Fortune 500 partnerships and was featured by the UN 2030 Agenda.
Now i feel good about my investment in TSNP.
CEO talking about European partner,could be RLFTF or NueroRx.IMO.
https://www.sec.gov/Archives/edgar/data/1557340/000107997320000919/optec_8k.htm
Its real deal as per sec filing.
Saliva/Blood/Mucus and CSF tests also under the scope of the work with ASU.
Feel free to read scope of work in Exhibit A page 10/12
HALB and ASU agreement
https://halberdcorporation.com/wp-content/uploads/2020/09/ASU-K-Fully-Executed.pdf
The Corporation shall not issue any convertible promissory notes, convertible preferred
stock or other convertible instruments. The Corporation shall be able to issue warrants
or options.
https://www.sos.state.co.us/biz/ViewImage.do?masterFileId=20201285635&fileId=20201595748
SIGNIFICANT NEWS IN WEEKS Jackson Center, PA, September 24, 2020 – Halberd Corporation (OTC PINK: “HALB“) clarifies next steps in their unique research with Arizona State University. Halberd directed their research program to focus on that element of Covid-19 which makes the disease most contagious — the spike antigen. ASU investigators have projected the production of the coronavirus spike antigen within the next two weeks.
The next steps for the ASU/Halberd program involve identification of an antibody conjugate which will fluoresce in the presence of the spike antigen to facilitate removal of the disease element via Halberd’s patented extracorporeal treatments. Feasibility samples of the spike antigen antibody conjugate are expected to be available within four weeks.
Availability of the antibody conjugate will allow for the development of a molecule, to be patented, which can be used in a diagnostic capacity – in a rapid-results test for the coronavirus – and possibly in an extracorporeal treatment regimen.
William A. Hartman, Halberd Corporation Chairman, President & CEO, stated, “With the successful creation of a fluorescent antibody, we hope to be able to create a rapid Covid-19 test using saliva or a drop of blood. We believe our approach will allow for accurate test results in a matter of minutes, and could be administered with minimal inconvenience/discomfort to those tested. Additionally, this approach could lead to a therapeutic application for coronavirus positive patients.”
Dr. Reyes added, “Facilitating this ease of identification has profound ramifications for both diagnostic purposes as well as therapeutic use including facilitated eradication of targeted antigens.”
Doctors Abdon Nanhay and Edson Brito further added “Our facilities in South America will be ideally suited for testing purposes. These initial tests could be the precursor to the commencement of FDA certification.”
The details of the Halberd-ASU research contract can be viewed here.
https://halberdcorporation.com/arizona-state-university-halberd-corp-covid-19-rd-program-rapid-diagnostic-test-treatment/
Dr. FELDMAN YOUTUBE EXPLANATION ABOUT THE PROCESS